
MART-1 32-40, ILTVILGVL
Description
About MART-1 32-40, ILTVILGVL
The Human Melanoma antigen recognized by T-cells 1 (MART-1) Peptide (IEDB: 27387) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanoma antigen recognized by T-cells 1 (MART-1) Peptide, H-ILTVILGVL-OH (Uniprot: Q16655 aa: 32-40) from JPT is produced under strict quality control and quality management.
MART-1 32-40, ILTVILGVL - Specifications
- Peptide sequence: H-ILTVILGVL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Vitiligo, Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for MART-1 32-40, ILTVILGVL
References:
Read References with JPT’s Antigen Peptides
MART-1 32-40, ILTVILGVL has been described in:
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay., Int J Cancer, 1997 (PMID: 9185691)
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies., Eur J Immunol, 1999 (PMID: 10540322)
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes., J Immunol, 2004 (PMID: 14764717)
Documentation
Documentation for MART-1 32-40, ILTVILGVL
Properties
Properties of MART-1 32-40, ILTVILGVL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma, Vitiligo |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Melanoma antigen recognized by T-cells 1 (MART-1) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to MART-1 32-40, ILTVILGVL
Information | Values |
---|---|
Sequence: | H-ILTVILGVL-OH |
Specifications: | 9mer peptide as TFA salt |